Proton Stereotactic Body Radiotherapy for Liver Metastases From Malignant Pancreatic Insulinoma
JCEM Case Reports · 18.09.2024 · 2 (10)
DOI: 10.1210/jcemcr/luae175 ↗Kurz gefasst
Fallbericht in der Zeitschrift JCEM Case Reports, online erschienen am 27.09.2024. Verfasst von Jake A Kloeber und 5 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic Medical Scientist Training Program, Mayo Clinic, Rochester, MN 55905, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Insulin-producing pancreatic tumors are a common subtype of neuroendocrine tumor. Standard of care includes surgical resection of the pancreatic tumor and medical management with somatostatin analogs. For patients with metastatic disease, tumor control and hypoglycemic symptom relief can be achieved through surgical resection of the tumor, hepatic artery embolization, radiofrequency ablation, or radioembolization using radioactive isotopes as well as with systemic therapy such as somatostatin analogs and everolimus. We present the case of a 74-year-old male with metastatic insulin-producing pancreatic carcinoma. After a long history of successfully controlling his hypoglycemic episodes post-liver wedge resection, bland embolizations subsequently failed to maintain control of the frequency and severity of his hypoglycemic symptoms. Stereotactic body radiotherapy (SBRT) with protons was used to achieve symptomatic control and led to partial radiographic response with complete resolution of his hypoglycemic episodes. This case demonstrates the potential utility of proton SBRT in metastatic insulinomas.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mayo Clinic Medical Scientist Training Program, Mayo Clinic, Rochester, MN 55905, USA.
- Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA.
- Department of Oncology, Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.
ORCID-Profile: Cameron M Callaghan
Förderung
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
Kloeber, J. A., Ebner, D. K., Jethwa, K. R., Merrell, K. W., Halfdanarson, T. R., & Callaghan, C. M. (2024). Proton Stereotactic Body Radiotherapy for Liver Metastases From Malignant Pancreatic Insulinoma. JCEM Case Reports, 2(10). https://doi.org/10.1210/jcemcr/luae175
Vancouver
Kloeber JA, Ebner DK, Jethwa KR, Merrell KW, Halfdanarson TR, Callaghan CM. Proton Stereotactic Body Radiotherapy for Liver Metastases From Malignant Pancreatic Insulinoma. JCEM Case Reports. 2024;2(10). doi:10.1210/jcemcr/luae175
BibTeX
@article{Kloeber2024,
author = {Kloeber, Jake A and Ebner, Daniel K and Jethwa, Krishan R and Merrell, Kenneth W and Halfdanarson, Thorvardur R and Callaghan, Cameron M},
title = {Proton Stereotactic Body Radiotherapy for Liver Metastases From Malignant Pancreatic Insulinoma},
journal = {JCEM Case Reports},
year = {2024},
volume = {2},
number = {10},
doi = {10.1210/jcemcr/luae175}
}
EUVIMED